v3.24.1.u1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 9,306 $ 5,562
Accounts receivable, net 143,237 113,192
Inventories, net 82,906 76,238
Fair value of derivative instruments 4,226 8,194
Contract assets 18,330 17,424
Prepaid expenses and other current assets 5,250 10,353
Total current assets 263,255 230,963
Property, plant and equipment, net 2,561,558 2,536,091
Operating lease right-of-use assets, net 32,444 33,716
Goodwill 305,553 305,553
Identifiable intangible assets, net 120,520 122,888
Fair value of derivative instruments 32,465 14,256
Other assets 636 639
Total assets 3,316,431 3,244,106
Current liabilities:    
Accounts payable 60,721 49,842
Total accrued liabilities 108,851 97,078
Contract liabilities 68,332 63,709
Total current liabilities 237,904 210,629
Long-term debt, net of unamortized debt issuance cost 1,828,259 1,791,460
Operating lease liabilities 33,901 34,468
Deferred tax liabilities 69,009 62,748
Other liabilities 2,385 2,148
Total liabilities 2,171,458 2,101,453
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, par value $— par value; $50,000 shares of preferred stock authorized, zero issued as of March 31, 2024, and December 31, 2023, respectively 0 0
Common stock, par value $— per share; $750,000 shares of common stock authorized, $77,435 and $77,400 shares of common stock issued and outstanding as of March 31, 2024, and December 31, 2023, respectively 774 774
Additional paid-in capital 965,732 963,760
Retained earnings 178,467 178,119
Total stockholders’ equity 1,144,973 1,142,653
Total liabilities and stockholders’ equity $ 3,316,431 $ 3,244,106

Source